Trends in Mail-Order Prescription Use among U.S. Adults from 1996 to 2018: A Nationally Representative Repeated Cross-Sectional Study

Evidence before this study In July 2020, major cost-cutting actions at the United States Postal Service (USPS) caused a sudden slowdown in mail delivery on a national scale. In addition to jeopardizing mail-in ballots for the upcoming November’s general election, such a remarkable postal delay may also deteriorate the health of many individuals who rely on the postal service to deliver their essential medications. The current SARS-CoV-2 epidemic may further amplify the postal crisis given anecdotal evidence that many patients have switched to mail-order prescriptions to avoid potential exposures to the virus at drugstores. Efforts aimed at addressing the health and economic effects of delayed medication delivery require an understanding of the national prevalence of mail-order prescription and the population groups who will likely be most affected by these postal delays. We searched PubMed for articles published on or before September 14, 2020 that described patterns of mail-order medication use using variations of the search terms “mail-order,” “medication,” and “United States.” We found no empirical evidence on trends in the use of mail-order medications at the national level or how such use varied by population subgroups.

Added value of this study To our knowledge, this study is the first to document time trends in the use of mail-order medications using data from a nationally representative cross-sectional sample of U.S. adults for each year from 1996 to 2018. Given the lack of evidence on the use of mail-order medications, the three key contributions of this study are to (i) demonstrate a relative increase of more than 50% in the prevalence of using mail-order prescription from 1996 to 2018, (ii) highlight population groups heavily relying on mail-order prescriptions and who are, thus, most likely to be affected by a decline in the availability or reliability of mail-order prescriptions from cost-cutting measures at the USPS, and (iii) document medications most commonly delivered by mail so that policy makers and clinicians can design effective interventions to alleviate the consequences of delayed or absent mail-order prescriptions.

Implications of all the available evidence We show that the use of mail-order medications has become more prevalent among U.S. adults over the past two decades, with an increase from 13.5 million adults in 1996 to 25.9 million adults in 2018. Given that USPS delivers 55% of all mail-order medications, a considerable proportion of mail-order pharmacy consumers could experience a delay or non-delivery of their medications. The use of mail-order medications is most common among older adults, disabled and chronically ill persons, and military-insured beneficiaries, who may have limited access to a local drugstore due to their morbidities or disability. In addition, we document a variety of medications frequently delivered by mail – ranging from those for which missing several doses does not result in immediate adverse health consequences (e.g. statins), to those for which missing a dose could be detrimental to the patient’s health (e.g. insulin). Our findings highlight that any disruption in the postal service could lead to important medical complications among a considerable proportion of the vulnerable U.S. population. The potential health consequences of a widespread national slowdown in mail delivery should be considered when weighing options to reverse recent changes at the USPS.